Onglyza FDA Warning Indicates Higher Risk of Heart Failure Among Similar Drugs
Top Class Actions,
In 2016, the FDA issued an Onglyza FDA warning regarding the increased risk for heart failure in patients taking the type-2…
In 2016, the FDA issued an Onglyza FDA warning regarding the increased risk for heart failure in patients taking the type-2…
Benjamin Scirica discusses his study group’s new analysis of data from the SAVOR-TIMI 53 randomized, placebo-controlled trial…
Conspiracy theorists and cranks, such as Mike Adams or Dr. Joseph Mercola, like to say that the Food and Drug Administration is…
Interview with Deepak L. Bhatt, MD, MPH, author of Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting…